Home
About
Overview
Sharing Data
ORCID
Help
History (2)
End points in cancer clinical trials and the drug approval process.
Prokaryotic Initiation Factors
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
End points in cancer clinical trials and the drug approval process.
End points in cancer clinical trials and the drug approval process. Clin Cancer Res. 2002 Apr; 8(4):935-8.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials as Topic
Drug Approval
Humans
Neoplasms
United States
United States Food and Drug Administration
authors with profiles
Richard Schilsky